Sign in
Predictors of clinical response: results from a large, randomized controlled study with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)
Journal article   Peer reviewed

Predictors of clinical response: results from a large, randomized controlled study with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)

S Strasser, H Chan, S Ahn, W Chuang, A Hui, F Tabak, R Mehta, J Petersen, C Lee, X Ma, …
Sep 2015

Metrics

2 Record Views

Details